ABOUT US > OUR GOVERNANCE > BOARD OF DIRECTORS > MAHA KATABI, PHD, CFA
BOARD OF DIRECTORS
MAHA KATABI, PHD, CFA
CHAIR OF THE BOARD OF EXACTIS INNOVATION, PARTNER SOFINNOVA
Dr. Maha Katabi joined Sofinnova as a Partner in 2019 and is a member of the Board of Directors for Amplyx Pharmaceuticals, Northsea Therapeutics and Chair of the Board of Exactis Innovation. In 2020, she was promoted to General Partner. She is an experienced investor in the bio-pharma sector with over two decades of venture capital investing and public equities portfolio management. Maha received her PhD in Pharmacology and BSc in Biology from McGill University and is a CFA charterholder.